State Street’s Dare Bioscience DARE Stock Holding History

State Street’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$100K	Buy	47,415 +23,900	+102%	+$53.4K	﹤0.01%	3969
2026 Q1	$42.8K	Hold	23,515	–	–	﹤0.01%	4148
2025 Q4	$45.4K	Hold	23,515	–	–	﹤0.01%	4169
2025 Q3	$49.4K	Hold	23,515	–	–	﹤0.01%	4159
2025 Q2	$56.2K	Hold	23,515	–	–	﹤0.01%	4079
2025 Q1	$68K	Hold	23,515	–	–	﹤0.01%	4044
2024 Q4	$73.4K	Hold	23,515	–	–	﹤0.01%	4058
2024 Q3	$76.2K	Sell	23,515 -3	-0%	-$10	﹤0.01%	4030
2024 Q2	$94.9K	Buy	23,518 +2,875	+14%	+$13.9K	﹤0.01%	4026
2024 Q1	$121K	Hold	20,643	–	–	﹤0.01%	3995
2023 Q4	$76.5K	Hold	20,643	–	–	﹤0.01%	4108
2023 Q3	$114K	Hold	20,643	–	–	﹤0.01%	4079
2023 Q2	$225K	Hold	20,643	–	–	﹤0.01%	3969
2023 Q1	$258K	Buy	20,643 +1,800	+10%	+$23.9K	﹤0.01%	3970
2022 Q4	$188K	Hold	18,843	–	–	﹤0.01%	4131
2022 Q3	$226K	Buy	18,843 +300	+2%	+$4.12K	﹤0.01%	4086
2022 Q2	$274K	Buy	18,543 +3,642	+24%	+$54.8K	﹤0.01%	4073
2022 Q1	$266K	Buy	14,901 +1,457	+11%	+$27.5K	﹤0.01%	4283
2021 Q4	$323K	Hold	13,444	–	–	﹤0.01%	4163
2021 Q3	$269K	Buy	13,444 +8,225	+158%	+$162K	﹤0.01%	4242
2021 Q2	$118K	Buy	+5,219	New	+$89.2K	﹤0.01%	4328
2017 Q3	–	Sell	-744	Closed	-$39K	–	3763
2017 Q2	$39K	Hold	744	–	–	﹤0.01%	3611
2017 Q1	$73K	Buy	+744	New	+$107K	﹤0.01%	3554

Other funds holding DARE

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State Street's DARE Position: Q2 2026 in Review

State Street increased its Dare Bioscience (DARE) stake by 102% in Q2 2026, buying an estimated $53.4K and bringing the position to 47,415 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

State Street first reported a position in DARE in Q1 2017 and has held it in 23 quarters since. The position peaked at $323K in Q4 2021. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

State Street held 47,415 shares of Dare Bioscience worth $100K as of Q2 2026.
State Street bought 23,900 Dare Bioscience shares in Q2 2026, an estimated $53.4K.
Dare Bioscience made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3969 holding.
State Street first reported a position in Dare Bioscience in Q1 2017 and has held it in 23 quarters since.
State Street's Dare Bioscience position peaked at $323K in Q4 2021.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.